Exact FDA event identifier

Event 91559

1 recalled-product record grouped only because every row carries this exact official event ID.

Event summary

Timeline bucket: November 09, 2022
Product types: Drug
Classifications: Class II
Statuses: Terminated
Recalling firm wording: DISCOVERY PHARMA LLC

Dossier provenance

Source snapshots represented here

openFDA Drug Enforcement Report-date coverage June 20, 2012–July 08, 2026 Known gap: openFDA describes 2004-present coverage, but the current export has no report-date records in this interval.

Enforcement coverage uses report dates; product initiation dates can precede those bounds. Device-enrichment coverage uses FDA event_date_initiated.

How coverage and grouping work

Device root-cause evidence is not applicable to this event. No grouped product has the official product type device; this is not an unavailable-enrichment finding.

Complete imported group

Every recalled product in this event

1 official enforcement rows

Product dates, classifications, firms, and source wording remain attached to their individual rows. Opening this dossier never hides products that did not match a prior timeline filter.

drug · product 1 of 1

Conzerol zero molluscum contagiosum, Homeopathic treatment for Molluscum Contagiosum, Topical Cream, Net weight 0.78 oz (22g) tube, UPC 8 60322 00180 8, Manufactured by: Dr. Retter EC Warszawska 17, 05-075 Warszawa Poland

D-0261-2023

Recall number: D-0261-2023
Initiated: November 09, 2022
Classification: Class II
Status: Terminated
Recalling firm: DISCOVERY PHARMA LLC
Quantity: 21,892 tubes

App-derived interpretation

Manufacturing or process control reason.manufacturing_process_control · v1.0.0

CGMP deviations

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

CGMP deviations

Code information

Lots: 22123 Exp. 01/2024; 21732 Exp. 07/2023

Distribution pattern

CA, FL, WA